(19)
(11) EP 4 770 681 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24866158.9

(22) Date of filing: 10.09.2024
(51) International Patent Classification (IPC): 
A61K 49/00(2006.01)
A61K 47/54(2017.01)
C09B 23/10(2006.01)
A61P 35/00(2006.01)
C07K 7/64(2006.01)
G01N 33/52(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07K 7/64; C09B 23/0025; C09B 23/0066; C09B 23/083; C09B 23/086; C09B 69/001; A61K 49/0032; A61K 49/0052; A61K 49/0056; A61K 49/006; C07K 14/78
(86) International application number:
PCT/US2024/045995
(87) International publication number:
WO 2025/059044 (20.03.2025 Gazette 2025/12)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 12.09.2023 US 202363538038 P
19.04.2024 US 202418641097

(71) Applicant: Curadel Surgical Innovations, Inc.
Bonita Springs, Florida 34135 (US)

(72) Inventor:
  • FRANGIONI, John V.
    Natick, Massachusetts 01760 (US)

(74) Representative: Prüfer & Partner mbB Patentanwälte · Rechtsanwälte 
Sohnckestraße 12
81479 München
81479 München (DE)

   


(54) TARGETING LIGANDS FOR DISEASE-TARGETED IMAGING AGENTS AND METHODS OF USE THEREFOR